D. Motta

发表

Influence of Hospitalization upon Diagnosis on the Risk of Tuberculosis Clustering

F. Zanini, A. Gori, L. Codecasa, 2013, Mediterranean journal of hematology and infectious diseases.

Increase in Standard Cholesterol and Large HDL Particle Subclasses in Antiretroviral-Naïve Patients Prescribed Efavirenz Compared to Atazanavir/Ritonavir

P. Narciso, R. Bellagamba, G. Guaraldi, 2012, HIV clinical trials.

A Randomized, Pilot Trial to Evaluate Glomerular Filtration Rate by Creatinine or Cystatin C in Naive HIV-Infected Patients After Tenofovir/Emtricitabine in Combination With Atazanavir/Ritonavir or Efavirenz

P. Narciso, R. Bellagamba, G. Guaraldi, 2012, Journal of acquired immune deficiency syndromes.

Prospective evaluation of bone markers, parathormone and 1,25-(OH)2 vitamin D in HIV-positive patients after the initiation of tenofovir/emtricitabine with atazanavir/ritonavir or efavirenz

P. Narciso, R. Bellagamba, B. Cesana, 2012, BMC Infectious Diseases.

Discordant Liver Fibrosis Predictors in Virologically Suppressed People Living with HIV without Hepatitis Virus Infection

M. Colaneri, L. Maiocchi, M. Puoti, 2021, Diagnostics.

The impact of gender and anchor drugs on TDF renal toxicity.

C. Torti, I. Izzo, G. Cristini, 2010, Journal of acquired immune deficiency syndromes.

EVALUATION OF THE INFLUENCE OF PROTEIN P53 IN PENILE CARCINOMA

A. Pompeo, D. Motta, Á. Sarkis, 2002 .

Risk factors for community-acquired bacterial meningitis: men who have sex with men (MSM) as a population at risk for meningococcal nasopharyngeal carriage

M. Puoti, G. Travi, C. Orcese, 2019, Infectious Diseases.

Impact of detectable human cytomegalovirus DNAemia on viro-immunological effectiveness of HAART in HIV-infected patients naive to antiretroviral therapy.

C. Torti, N. Manca, E. Quiros-Roldan, 2012, The new microbiologica.

Virological effectiveness and CD4+ T-cell increase over early and late courses in HIV infected patients on antiretroviral therapy: focus on HCV and anchor class received

S. Di Giambenedetto, C. Torti, M. Fabbiani, 2012, AIDS Research and Therapy.

Factors influencing the normalization of CD4+ T-cell count, percentage and CD4+/CD8+ T-cell ratio in HIV-infected patients on long-term suppressive antiretroviral therapy.

M. Prosperi, I. Frank, C. Torti, 2012, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Screening for Neurocognitive Impairment in HIV-Infected Individuals at First Contact after HIV Diagnosis: The Experience of a Large Clinical Center in Northern Italy

P. Rodari, F. Castelli, M. Pezzoli, 2016, International journal of molecular sciences.

Long-lasting humoral immune response induced in HIV-1-infected patients by a synthetic peptide (AT20) derived from the HIV-1 matrix protein p17 functional epitope

C. Giagulli, F. Castelli, S. Fiorentini, 2015, HIV Clinical Trials.

Atazanavir/ritonavir with lamivudine as maintenance therapy in virologically suppressed HIV-infected patients: 96 week outcomes of a randomized trial

P. Narciso, A. Lazzarin, A. Giacomelli, 2018, The Journal of antimicrobial chemotherapy.

Unboosted Atazanavir for Treatment of HIV Infection

C. Torti, D. Ripamonti, D. Motta, 2012, Drugs.

Effectiveness of routine lumbar puncture in patients with HIV-associated Dementia (HAD) receiving suppressive antiretroviral treatment

F. Castelli, C. Torti, M. Pezzoli, 2015 .

Elderly Women With Human Immunodeficiency Virus Infection: Is There an Effect of the Virus on Neuropsychological Profile?

F. Castelli, G. Romanelli, E. Quiros Roldan, 2014, Journal of the American Geriatrics Society.

Antiretroviral Therapy in HIV/HCV Co-Infection Italian Consensus Workshop

E. Pontali, G. Carosi, M. Puoti, 2013 .